Latest Share Chat

REMOVE ADS

Celadon Pharmaceuticals Share News (CEL)

Celadon Pharmaceuticals Information

This share is currently suspended. It was suspended at a price of 13.40

There is currently no data for CEL

REMOVE ADS

Celadon Pharmaceuticals News

UK shareholder meetings calendar - next 7 days

IN BRIEF: Celadon Pharma posts widened loss in 16-month period

Celadon Pharmaceuticals Plc - London-based manufacturer and supplier of cannabinoid-based medicines formerly known as Summerway Capital PLC - Posts wi...

Summerway to buy medicinal cannabis group Vertigrow

(Sharecast News) - Summerway Capital has agreed to buy Vertigrow Technology, a medicinal cannabis producer, for £80m to take the business public ...

Caparo Energy obtains first phase of financing

Caparo Energy has today disclosed that it has obtained a first round of financing, for Rs 3,500m (US$78.5m), from the India Infrastructure Fund. The...

Caparo Energy finalises debt facility

India-focused wind power generation investor Caparo Energy unveiled a $0.44m loss in its first set of interim results since listing on AIM in November...

Caparo raises £50.2m in AIM float

India-focused wind power generation investor Caparo Energy has joined AIM today after a £50.2m fund raising. The net proceeds of the placing at 115p...

Celsis gets 232.5p cash offer

Diagnostics group Celsis has agreed to a cash offer worth 232.5p per share or £54.5m in total from private equity group North Atlantic Value. Celsis ...

London close: Rally continues

Footsie finished just shy of the 4,500 mark after another day of gains as the rally continues. Wm Morrison led the way after saying it is confident f...